Award Timing Disclosure |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Aug. 11, 2025
USD ($)
shares
$ / shares
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing Disclosures [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing MNPI Disclosure | In accordance with Item 402(x) of Regulation S-K under the Securities Act of 1933, as amended, we are providing information regarding our procedures related to the grant of certain equity awards close in time to the release of material non-public information (“MNPI”). Although we do not have a formal policy, program or plan that requires us to award equity or equity-based compensation on specific dates, we generally expect our Compensation Committee to approve and grant equity awards to our executive officers annually. Additionally, our insider trading policy prohibits directors, officers and employees from trading in our common stock while in possession of or on the basis of MNPI about us. We have not timed, and do not plan to time, the disclosure of MNPI for the purpose of affecting the value of executive compensation.
In the year ended March 31, 2026, the following options were granted to our named executive officers within four business days prior to, or one business day following, the filing or furnishing of a periodic or current report by us that disclosed MNPI.
(1)
We filed a quarterly report on Form 10-Q on August 12, 2025. The percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information was approximately 6.3%. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing Method | Although we do not have a formal policy, program or plan that requires us to award equity or equity-based compensation on specific dates, we generally expect our Compensation Committee to approve and grant equity awards to our executive officers annually. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing Predetermined | true | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing MNPI Considered | true | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing, How MNPI Considered | Additionally, our insider trading policy prohibits directors, officers and employees from trading in our common stock while in possession of or on the basis of MNPI about us. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MNPI Disclosure Timed for Compensation Value | false | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures, Table | In the year ended March 31, 2026, the following options were granted to our named executive officers within four business days prior to, or one business day following, the filing or furnishing of a periodic or current report by us that disclosed MNPI.
We filed a quarterly report on Form 10-Q on August 12, 2025. The percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information was approximately 6.3%. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Underlying Security Market Price Change | 6.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tony Lialin [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Name | Tony Lialin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Underlying Securities | shares | 40,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise Price | $ / shares | $ 1.78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value as of Grant Date | $ | $ 60,177 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Underlying Security Market Price Change | 6.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||